Wenfu Tan

1.6k total citations
46 papers, 1.3k citations indexed

About

Wenfu Tan is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Wenfu Tan has authored 46 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 16 papers in Oncology and 4 papers in Genetics. Recurrent topics in Wenfu Tan's work include Hedgehog Signaling Pathway Studies (23 papers), Cancer-related Molecular Pathways (7 papers) and Epigenetics and DNA Methylation (7 papers). Wenfu Tan is often cited by papers focused on Hedgehog Signaling Pathway Studies (23 papers), Cancer-related Molecular Pathways (7 papers) and Epigenetics and DNA Methylation (7 papers). Wenfu Tan collaborates with scholars based in China, United States and Canada. Wenfu Tan's co-authors include J. Silvio Gutkind, Panomwat Amornphimoltham, Jian Ding, Daniel Martı́n, Liping Lin, Yi Zheng, Todd R. Palmby, Julie Gavard, Jun Yang and Yunguang Tong and has published in prestigious journals such as Journal of Biological Chemistry, JNCI Journal of the National Cancer Institute and Clinical Cancer Research.

In The Last Decade

Wenfu Tan

45 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenfu Tan China 19 947 320 178 135 112 46 1.3k
Kyung Song United States 22 1.1k 1.1× 341 1.1× 280 1.6× 124 0.9× 178 1.6× 50 1.6k
Peter Canning United Kingdom 14 1.2k 1.3× 258 0.8× 126 0.7× 145 1.1× 144 1.3× 21 1.6k
K. M. Nicholson United Kingdom 4 1.1k 1.2× 380 1.2× 227 1.3× 105 0.8× 112 1.0× 6 1.5k
Xiaohong Yang China 17 610 0.6× 247 0.8× 183 1.0× 77 0.6× 119 1.1× 56 1.1k
Mustapha Kandouz United States 25 979 1.0× 305 1.0× 279 1.6× 112 0.8× 109 1.0× 42 1.6k
Yancun Yin China 18 654 0.7× 198 0.6× 232 1.3× 186 1.4× 92 0.8× 33 1.2k
Sivaprakasam Balasubramanian United States 21 817 0.9× 261 0.8× 152 0.9× 175 1.3× 130 1.2× 30 1.4k
Hee Jun Cho South Korea 24 926 1.0× 386 1.2× 267 1.5× 192 1.4× 174 1.6× 53 1.4k
Junchen Liu China 23 686 0.7× 253 0.8× 207 1.2× 97 0.7× 142 1.3× 53 1.2k
Baskaran Govindarajan United States 21 1000 1.1× 412 1.3× 221 1.2× 159 1.2× 276 2.5× 26 1.8k

Countries citing papers authored by Wenfu Tan

Since Specialization
Citations

This map shows the geographic impact of Wenfu Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenfu Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenfu Tan more than expected).

Fields of papers citing papers by Wenfu Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenfu Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenfu Tan. The network helps show where Wenfu Tan may publish in the future.

Co-authorship network of co-authors of Wenfu Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Wenfu Tan. A scholar is included among the top collaborators of Wenfu Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenfu Tan. Wenfu Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Xu, Zhongli, et al.. (2024). Sorafenib and SIAIS361034, a novel PROTAC degrader of BCL-xL, display synergistic antitumor effects on hepatocellular carcinoma with minimal hepatotoxicity. Biochemical Pharmacology. 230(Pt 1). 116542–116542. 3 indexed citations
3.
Wang, Zhaofu, et al.. (2024). A Selective FGFR1/2 PROTAC Degrader with Antitumor Activity. Molecular Cancer Therapeutics. 23(8). 1084–1094. 5 indexed citations
4.
Duan, Biao, Shaoqing Zhang, Yue Chen, et al.. (2023). BRD4-binding enhancer promotes CRC progression by interacting with YY1 to activate the Wnt pathway through upregulation of TCF7L2. Biochemical Pharmacology. 218. 115877–115877. 1 indexed citations
5.
Cai, Weisong, Yanli Li, Wenfu Tan, et al.. (2023). SNHG3/hsa-miR-455-5p Axis-mediated High Expression of MTHFD2 Correlates with Tumor Immune Infiltration and Endometrial Carcinoma Progression. International Journal of Medical Sciences. 20(8). 1097–1113. 4 indexed citations
6.
Luo, Jia, Juan Wang, Jun Yang, et al.. (2022). Saikosaponin B1 and Saikosaponin D inhibit tumor growth in medulloblastoma allograft mice via inhibiting the Hedgehog signaling pathway. Journal of Natural Medicines. 76(3). 584–593. 13 indexed citations
7.
Yang, Jun, Juan Wang, Yu Zhang, et al.. (2022). c-Jun phosphorylated by JNK is required for protecting Gli2 from proteasomal-ubiquitin degradation by PGE2-JNK signaling axis. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1870(3). 119418–119418. 5 indexed citations
8.
Huang, Wenjing, et al.. (2022). ABT-737 suppresses aberrant Hedgehog pathway and overcomes resistance to smoothened antagonists by blocking Gli. Medical Oncology. 39(12). 188–188. 1 indexed citations
9.
Yang, Jun, Yuan Liu, Yu Zhang, et al.. (2021). PGE2-JNK signaling axis non-canonically promotes Gli activation by protecting Gli2 from ubiquitin-proteasomal degradation. Cell Death and Disease. 12(7). 707–707. 9 indexed citations
10.
Li, Zhengmao, Yong Fu, Wei Ouyang, et al.. (2021). Circ_0016347 Promotes Osteosarcoma Progression by Regulating miR-1225-3p/KCNH1 Axis. Cancer Biotherapy and Radiopharmaceuticals. 38(9). 619–631. 11 indexed citations
11.
Yang, Jun, et al.. (2020). Discovery of Small Molecule Inhibitors Targeting the Sonic Hedgehog. Frontiers in Chemistry. 8. 498–498. 10 indexed citations
12.
Ding, Kang, Yiqing Zhou, Yang Liu, et al.. (2019). Colocalization Strategy Unveils an Underside Binding Site in the Transmembrane Domain of Smoothened Receptor. Journal of Medicinal Chemistry. 62(21). 9983–9989. 5 indexed citations
13.
Liu, Xiaohua, Yu Zhang, Wenjing Huang, et al.. (2018). Development of high potent and selective Bcl-2 inhibitors bearing the structural elements of natural product artemisinin. European Journal of Medicinal Chemistry. 159. 149–165. 11 indexed citations
14.
Chen, Yuzhe, Qiang Xiao, Rong Qu, et al.. (2018). Discovery of novel 2,4-diarylaminopyrimidine derivatives as potent and selective epidermal growth factor receptor (EGFR) inhibitors against L858R/T790M resistance mutation. European Journal of Medicinal Chemistry. 152. 298–306. 10 indexed citations
15.
16.
Li, Jiaxin, et al.. (2014). Natural product-based design, synthesis and biological evaluation of anthra[2,1-d]thiazole-6,11-dione derivatives from rhein as novel antitumour agents. European Journal of Medicinal Chemistry. 84. 505–515. 18 indexed citations
17.
Yagi, Hiroshi, Wenfu Tan, Patrícia Dillenburg-Pilla, et al.. (2011). A Synthetic Biology Approach Reveals a CXCR4-G 13 -Rho Signaling Axis Driving Transendothelial Migration of Metastatic Breast Cancer Cells. Science Signaling. 4(191). ra60–ra60. 115 indexed citations
18.
Tan, Wenfu, Daniel Martı́n, & J. Silvio Gutkind. (2006). The Gα13-Rho Signaling Axis Is Required for SDF-1-induced Migration through CXCR4. Journal of Biological Chemistry. 281(51). 39542–39549. 122 indexed citations
19.
Tong, Yunguang, Xiongwen Zhang, Weimin Zhao, et al.. (2004). Anti-angiogenic effects of Shiraiachrome A, a compound isolated from a Chinese folk medicine used to treat rheumatoid arthritis. European Journal of Pharmacology. 494(2-3). 101–109. 39 indexed citations
20.
Tan, Wenfu, Xiongwen Zhang, Jian‐Min Yue, et al.. (2004). Pseudolarix acid B inhibits angiogenesis by antagonizing the vascular endothelial growth factor-mediated anti-apoptotic effect. European Journal of Pharmacology. 499(3). 219–228. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kyung Song Breakdown of academic impact, for papers by Peter Canning Breakdown of academic impact, for papers by K. M. Nicholson Breakdown of academic impact, for papers by Xiaohong Yang Breakdown of academic impact, for papers by Mustapha Kandouz Breakdown of academic impact, for papers by Yancun Yin Breakdown of academic impact, for papers by Sivaprakasam Balasubramanian Breakdown of academic impact, for papers by Hee Jun Cho Breakdown of academic impact, for papers by Junchen Liu Breakdown of academic impact, for papers by Baskaran Govindarajan
Rankless by CCL
2026